Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68


Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.

Barnes MD, Taracila MA, Good CE, Bajaksouzian S, Rojas LJ, van Duin D, Kreiswirth BN, Jacobs MR, Haldimann A, Papp-Wallace KM, Bonomo RA.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00432-19. doi: 10.1128/AAC.00432-19. Print 2019 Aug.


Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor Combination.

Papp-Wallace KM, Bethel CR, Caillon J, Barnes MD, Potel G, Bajaksouzian S, Rutter JD, Reghal A, Shapiro S, Taracila MA, Jacobs MR, Bonomo RA, Jacqueline C.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e00105-19. doi: 10.1128/AAC.00105-19. Print 2019 May.


Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234.

Papp-Wallace KM, Nguyen NQ, Jacobs MR, Bethel CR, Barnes MD, Kumar V, Bajaksouzian S, Rudin SD, Rather PN, Bhavsar S, Ravikumar T, Deshpande PK, Patil V, Yeole R, Bhagwat SS, Patel MV, van den Akker F, Bonomo RA.

J Med Chem. 2018 May 10;61(9):4067-4086. doi: 10.1021/acs.jmedchem.8b00091. Epub 2018 Apr 20.


Effect of alcohol-based hand rub on hand microbiome and hand skin health in hospitalized adult stem cell transplant patients: A pilot study.

Mukherjee PK, Chandra J, Retuerto M, Arters KA, Consolo MC, Patterson A, Bajaksouzian S, Arbogast JW, Cartner TJ, Jacobs MR, Ghannoum MA, Salata RA.

J Am Acad Dermatol. 2018 Jun;78(6):1218-1221.e5. doi: 10.1016/j.jaad.2017.11.046. Epub 2017 Dec 1. No abstract available.


Bacterial Colonization and Antibiotic Resistance in a Prospective Cohort of Newborn Infants During the First Year of Life.

Meropol SB, Stange KC, Jacobs MR, Weiss JK, Bajaksouzian S, Bonomo RA.

Open Forum Infect Dis. 2016 Dec 5;3(4):ofw221. eCollection 2016 Oct. Erratum in: Open Forum Infect Dis. 2017 Jun 17;4(2):ofx114.


Erratum for "New Insights into Dissemination and Variation of the Health Care-Associated Pathogen Acinetobacter baumannii from Genomic Analysis".

Wright MS, Haft DH, Harkins DM, Perez F, Hujer KM, Bajaksouzian S, Benard MF, Jacobs MR, Bonomo RA, Adams MD.

MBio. 2015 Jun 4;6(3):e00585. doi: 10.1128/mBio.00585-15. No abstract available.


SISPA-Seq for rapid whole genome surveys of bacterial isolates.

Wright MS, Stockwell TB, Beck E, Busam DA, Bajaksouzian S, Jacobs MR, Bonomo RA, Adams MD.

Infect Genet Evol. 2015 Jun;32:191-8. doi: 10.1016/j.meegid.2015.03.018. Epub 2015 Mar 19.


Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.

Papp-Wallace KM, Bajaksouzian S, Abdelhamed AM, Foster AN, Winkler ML, Gatta JA, Nichols WW, Testa R, Bonomo RA, Jacobs MR.

Diagn Microbiol Infect Dis. 2015 May;82(1):65-9. doi: 10.1016/j.diagmicrobio.2015.02.003. Epub 2015 Feb 14.


Risk factors for microbial bioburden during daily wear of silicone hydrogel contact lenses.

Jiang Y, Jacobs M, Bajaksouzian S, Foster AN, Debanne SM, Bielefeld R, Garvey M, Raghupathy S, Kern J, Szczotka-Flynn LB.

Eye Contact Lens. 2014 May;40(3):148-56. doi: 10.1097/ICL.0000000000000026.


New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis.

Wright MS, Haft DH, Harkins DM, Perez F, Hujer KM, Bajaksouzian S, Benard MF, Jacobs MR, Bonomo RA, Adams MD.

MBio. 2014 Jan 21;5(1):e00963-13. doi: 10.1128/mBio.00963-13. Erratum in: MBio. 2015;6(3):e00585.


In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii.

Russo TA, Page MG, Beanan JM, Olson R, Hujer AM, Hujer KM, Jacobs M, Bajaksouzian S, Endimiani A, Bonomo RA.

J Antimicrob Chemother. 2011 Apr;66(4):867-73. doi: 10.1093/jac/dkr013. Epub 2011 Feb 13.


Bacterial conversion of folinic acid is required for antifolate resistance.

Ogwang S, Nguyen HT, Sherman M, Bajaksouzian S, Jacobs MR, Boom WH, Zhang GF, Nguyen L.

J Biol Chem. 2011 Apr 29;286(17):15377-90. doi: 10.1074/jbc.M111.231076. Epub 2011 Mar 3.


Bacterial clearance of biologic grafts used in hernia repair: an experimental study.

Harth KC, Broome AM, Jacobs MR, Blatnik JA, Zeinali F, Bajaksouzian S, Rosen MJ.

Surg Endosc. 2011 Jul;25(7):2224-9. doi: 10.1007/s00464-010-1534-8. Epub 2011 Feb 7.


Novel bis-indole agents active against multidrug-resistant Acinetobacter baumannii.

Jacobs MR, Bajaksouzian S, Good CE, Butler MM, Williams JD, Peet NP, Bowlin TL, Endimiani A, Bonomo RA.

Diagn Microbiol Infect Dis. 2011 Jan;69(1):114-6. doi: 10.1016/j.diagmicrobio.2010.08.014.


Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility.

Endimiani A, Perez F, Bajaksouzian S, Windau AR, Good CE, Choudhary Y, Hujer AM, Bethel CR, Bonomo RA, Jacobs MR.

J Clin Microbiol. 2010 Dec;48(12):4417-25. doi: 10.1128/JCM.02458-09. Epub 2010 Sep 29.


Antibiotic-releasing mesh coating to reduce prosthetic sepsis: an in vivo study.

Harth KC, Rosen MJ, Thatiparti TR, Jacobs MR, Halaweish I, Bajaksouzian S, Furlan J, von Recum HA.

J Surg Res. 2010 Oct;163(2):337-43. doi: 10.1016/j.jss.2010.03.065. Epub 2010 Apr 24.


Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.

Perez F, Endimiani A, Ray AJ, Decker BK, Wallace CJ, Hujer KM, Ecker DJ, Adams MD, Toltzis P, Dul MJ, Windau A, Bajaksouzian S, Jacobs MR, Salata RA, Bonomo RA.

J Antimicrob Chemother. 2010 Aug;65(8):1807-18. doi: 10.1093/jac/dkq191. Epub 2010 May 31.


Comparison of transformation frequencies among selected Streptococcus pneumoniae serotypes.

Joloba ML, Kidenya BR, Kateete DP, Katabazi FA, Muwanguzi JK, Asiimwe BB, Alarakol SP, Nakavuma JL, Bajaksouzian S, Windau A, Jacobs MR.

Int J Antimicrob Agents. 2010 Aug;36(2):124-8. doi: 10.1016/j.ijantimicag.2010.03.024. Epub 2010 May 15.


Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.

Jacobs MR, Good CE, Windau AR, Bajaksouzian S, Biek D, Critchley IA, Sader HS, Jones RN.

Antimicrob Agents Chemother. 2010 Jun;54(6):2716-9. doi: 10.1128/AAC.01797-09. Epub 2010 Mar 22.


Validation of factor 6d antiserum for serotyping Streptococcus pneumoniae serotype 6C.

Jacobs MR, Dagan R, Bajaksouzian S, Windau AR, Porat N.

J Clin Microbiol. 2010 Apr;48(4):1456-7. doi: 10.1128/JCM.01907-09. Epub 2010 Feb 17.


Risk factors for contact lens bacterial contamination during continuous wear.

Szczotka-Flynn LB, Bajaksouzian S, Jacobs MR, Rimm A.

Optom Vis Sci. 2009 Nov;86(11):1216-26. doi: 10.1097/OPX.0b013e3181bbca18.


Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system.

Adams MD, Nickel GC, Bajaksouzian S, Lavender H, Murthy AR, Jacobs MR, Bonomo RA.

Antimicrob Agents Chemother. 2009 Sep;53(9):3628-34. doi: 10.1128/AAC.00284-09. Epub 2009 Jun 15.


Molecular characterisation of meticillin-resistant Staphylococcus aureus isolates from two ceftobiprole Phase 3 complicated skin and skin-structure infection clinical trials.

Davies TA, Shang W, Amsler KM, Bajaksouzian S, Jacobs MR, Bush K.

Int J Antimicrob Agents. 2009 Aug;34(2):166-8. doi: 10.1016/j.ijantimicag.2009.02.013. Epub 2009 Apr 2.


Occurrence, distribution, and origins of Streptococcus pneumoniae Serotype 6C, a recently recognized serotype.

Jacobs MR, Bajaksouzian S, Bonomo RA, Good CE, Windau AR, Hujer AM, Massire C, Melton R, Blyn LB, Ecker DJ, Sampath R.

J Clin Microbiol. 2009 Jan;47(1):64-72. doi: 10.1128/JCM.01524-08. Epub 2008 Oct 29.


Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience.

Jacobs MR, Good CE, Beall B, Bajaksouzian S, Windau AR, Whitney CG.

J Clin Microbiol. 2008 Mar;46(3):982-90. doi: 10.1128/JCM.02321-07. Epub 2008 Jan 30.


Characterization of penicillin intermediate serotypes of Streptococcus pneumoniae carried by human immunodeficiency virus-infected adults and healthy children in Uganda.

Blossom DB, Cordeiro SM, Bajaksouzian S, Joloba ML, Kityo C, Whalen CC, Salata RA, Jacobs MR.

Microb Drug Resist. 2007 Spring;13(1):21-8.


Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center.

Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA.

Antimicrob Agents Chemother. 2006 Dec;50(12):4114-23. Epub 2006 Sep 25.


Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility.

Blossom DB, Namayanja-Kaye G, Nankya-Mutyoba J, Mukasa JB, Bakka H, Rwambuya S, Windau A, Bajaksouzian S, Walker CJ, Joloba ML, Kityo C, Mugyenyi P, Whalen CC, Jacobs MR, Salata RA.

Int J Infect Dis. 2006 Nov;10(6):458-64. Epub 2006 Sep 25.


Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004.

Yomtovian RA, Palavecino EL, Dysktra AH, Downes KA, Morrissey AM, Bajaksouzian S, Pokorny MA, Lazarus HM, Jacobs MR.

Transfusion. 2006 May;46(5):719-30.


Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones.

Reinert RR, Jacobs MR, Appelbaum PC, Bajaksouzian S, Cordeiro S, van der Linden M, Al-Lahham A.

J Clin Microbiol. 2005 Dec;43(12):6035-41.


Evaluation of the Scansystem method for detection of bacterially contaminated platelets.

Jacobs MR, Bajaksouzian S, Windau A, Palavecino EL, Yomtovian R.

Transfusion. 2005 Feb;45(2):265-9.


Alterations of penicillin-binding proteins 1A, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs.

Kosowska K, Jacobs MR, Bajaksouzian S, Koeth L, Appelbaum PC.

Antimicrob Agents Chemother. 2004 Oct;48(10):4020-2.


In vitro activity of the new quinolone WCK 771 against staphylococci.

Jacobs MR, Bajaksouzian S, Windau A, Appelbaum PC, Patel MV, Gupte SV, Bhagwat SS, De Souza NJ, Khorakiwala HF.

Antimicrob Agents Chemother. 2004 Sep;48(9):3338-42.


Clinically significant concentrations of local anesthetics inhibit Staphylococcus aureus in vitro.

Goodman EJ, Jacobs MR, Bajaksouzian S, Windau AR, Dagirmanjian JP.

Int J Obstet Anesth. 2002 Apr;11(2):95-9.


Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 Gram-positive cocci.

Jacobs MR, Bajaksouzian S, Appelbaum PC.

J Antimicrob Chemother. 2003 Nov;52(5):809-12. Epub 2003 Sep 30.


Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile.

Palavecino EL, Riedel I, Duran C, Bajaksouzian S, Joloba M, Davies T, Appelbaum PC, Jacobs MR.

Int J Antimicrob Agents. 2002 Aug;20(2):108-12.


Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzae.

Jacobs MR, Bajaksouzian S, Windau A, Appelbaum PC, Lin G, Felmingham D, Dencer C, Koeth L, Singer ME, Good CE.

J Clin Microbiol. 2002 Sep;40(9):3269-76.


Antimicrobial susceptibility of Streptococcus pneumoniae from children attending day-care centers in a central Italian city.

Ronchetti MP, Merolla R, Bajaksouzian S, Violo G, Ronchetti R, Jacobs MR.

Clin Microbiol Infect. 1998 Jan;4(11):622-626.


Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media.

Joloba ML, Windau A, Bajaksouzian S, Appelbaum PC, Hausdorff WP, Jacobs MR.

Clin Infect Dis. 2001 Nov 1;33(9):1489-94. Epub 2001 Oct 4.


High prevalence of carriage of antibiotic-resistant Streptococcus pneumoniae in children in Kampala Uganda.

Joloba ML, Bajaksouzian S, Palavecino E, Whalen C, Jacobs MR.

Int J Antimicrob Agents. 2001 May;17(5):395-400.


Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.

Palavecino EL, Riedel I, Berrios X, Bajaksouzian S, Johnson D, Kaplan E, Jacobs MR.

Antimicrob Agents Chemother. 2001 Jan;45(1):339-41.


Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agents.

Credito KL, Lin G, Pankuch GA, Bajaksouzian S, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 2001 Jan;45(1):67-72.


Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.

Joloba ML, Bajaksouzian S, Jacobs MR.

J Clin Microbiol. 2000 Oct;38(10):3834-6.


Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.

Joloba ML, Whalen CC, Cave DM, Eisenach KD, Johnson JL, Okwera A, Morrissey A, Bajaksouzian S, Feagin J, Mugerwa R, Ellner J, Jacobs MR.

East Afr Med J. 2000 Feb;77(2):111-5.


Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.

Davies TA, Kelly LM, Hoellman DB, Ednie LM, Clark CL, Bajaksouzian S, Jacobs MR, Appelbaum PC.

Antimicrob Agents Chemother. 2000 Mar;44(3):633-9.

Supplemental Content

Loading ...
Support Center